Gawlitza A: Difference between revisions
From Bioblast
No edit summary |
Nirschl Lisa (talk | contribs) No edit summary Β |
||
(4 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{{Person}} | {{Person | ||
|lastname=Gawlitza | |||
|firstname=Alexander | |||
|institution=University Medical Center of Mainz | |||
|address=LangenbeckstraΓe 1 | |||
|area code=Dβ55131 | |||
|city=Mainz | |||
|country=Germany | |||
|mailaddress=alexgawl86@gmail.com | |||
}} | |||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | |||
::::* [[IOC96| IOC96 Schroecken AT]] |
Latest revision as of 12:11, 13 February 2018
Name | Gawlitza Alexander, |
---|---|
Institution | University Medical Center of Mainz |
Address | LangenbeckstraΓe 1, Dβ55131 |
City | Mainz |
State/Province | |
Country | Germany |
alexgawl86@gmail.com | |
Weblink | |
O2k-Network Lab | DE Mainz Methner A |
Labels:
Publications
Published | Reference | |
---|---|---|
Lisak 2015 Cell Death Differ | 2015 | Lisak D, Schacht T, Gawlitza A, Albrecht P, Aktas O, Koop B, Gliem M, Hofstetter HH, Zanger K, Bultynck G, Parys JB, De Smedt H, Kindler T, Adams-Quack P, Hahn M, Waisman A, Reed JC, HΓΆvelmeyer N, Methner A (2015) BAX inhibitor-1 is a Ca2+ channel critically important for immune cell function and survival. Cell Death Differ 23:358-68. |
Abstracts